Sleep Medicine Reviews
Volume 5, Issue 1 , Pages 7-23 , February 2001

Optimal continuous positive airway pressure for the treatment of obstructive sleep apnea/hypopnea

  • William Beninati

      Affiliations

    • Pulmonary and Critical Care Medicine, Wilford Hall USAF Medical Center and Uniformed Services University of the Health Sciences, University of Pittsburgh School of Medicine Pulmonary Service, Veterans Affairs Health Care System of Pittsburgh USA, Pittsburgh, USA
    • ,
  • Mark H Sanders

      Affiliations

    • Pulmonary Sleep Disorders Program, Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine Pulmonary Service, Veterans Affairs Health Care System of Pittsburgh USA, Pittsburgh, USA

References 

  1. American Academy of Sleep Medicine Task Force . Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep. 1999;22:667–689
  2. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230–1230
  3. Ballester E, Badia JR, Hernandez L. Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1999;159:495–501
  4. Redline S, Adams N, Strauss ME, Roebuck T, Winters M, Rosenberg C. Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy. Am J Respir Crit Care Med. 1998;157:858–865
  5. Engleman HM, Martin SE, Kingshott RN, Mackay TW, Deary IJ, Douglas NJ. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax. 1998;53:341–345
  6. Engleman HM, Kingshott RN, Wraith PK, Mackay TW, Deary IJ, Douglas NJ. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1999;159:461–467
  7. Jenkinson C, Davies RJO, Mullins R, Stradling JR. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for abstructive sleep apnoea: a randomised prospective parallel trial. Lancet. 1999;353:2100–2105
  8. Guilleminault C, Partinen M, Quera-Salve MA, Hayes B, Dement WC, Nino-Murcia G. Determinants of daytime sleepiness in obstructive sleep apnea. Chest. 1988;94:32–37
  9. Colt HG, Haas H, Rich GB. Hypoxemia vs sleep fragmentation as cause of excessive daytime sleepiness in obstructive sleep apnea. Chest. 1991;100:1542–1548
  10. Teran-Santos J, Jimenez-Gomez A, Cordero-Guevara J. The association between sleep apnea and the risk of traffic accidents. N Engl J Med. 1999;340:847–851
  11. George CFP, Smiley A. Sleep apnea and automobile crashes. Sleep. 1999;22:790–795
  12. Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B, et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med. 1997;157:1746–1752
  13. Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Phillipson EA. Obstructive sleep apnea as a cause of systemic hypertension: evidence from a canine model. J Clin Invest. 1997;99:106–109
  14. Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients: mortality. Chest. 1988;94:1200–1204
  15. He J, Kryger MH, Zorick FJ, Conway W, Roth T. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest. 1988;94:9–14
  16. Quan SF, Howard BV, Iber C. The Sleep Heart Health Study: design, rationale, and methods. Sleep. 1997;20:1077–1085
  17. Strollo PJ, Roberts RM. Obstructive sleep apnea. N Engl J Med. 1996;334:99–104
  18. Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981;1(8225):862–865
  19. Sanders MH, Moore SE, Eveslage J. CPAP via nasal mask: a treatment for occlusive sleep apnea. Chest. 1983;83:144–145
  20. Abbey NC, Cooper KR, Kwentus JA. Benefit of nasal CPAP in obstructive sleep apnea is due to positive pharyngeal pressure. Sleep. 1989;12:420–422
  21. Mortimore IL, Douglas NJ. Palatal muscle EMG response to negative pressure in awake sleep apneic and control subjects. Am J Respir Crit Care Med. 1997;156:867–873
  22. Lin CC. Effect of nasal CPAP on ventilatory drive in normocapnic and hypercapnic patients with obstructive sleep apnoea syndrome. Euro Respir J. 1994;7:2005–2010
  23. Ryan CF, Lowe AA, Li D, Fleetham JA. Magnetic resonance imaging of the upper airway in obstructive sleep apnea before and after chronic nasal continuous positive airway pressure therapy. Am Rev Respir Dis. 1991;144:939–944
  24. Pepin JL, Leger P, Veale D, Langevin B, Robert D, Levy P. Side effects of nasal continuous positive airway pressure in sleep apnea syndrome: study of 193 patients in two French sleep centers. Chest. 1995;107:375–381
  25. Kribbs NB, Pack AI, Kline LR. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis. 1993;147:887–895
  26. American Thoracic Soociety . Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. Official statement. Am J Respir Crit Care Med. 1994;150:1738–1745
  27. Loube DI, Gay PC, Strohl KP, Pack AI, White DP, Collop NA. Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: a consensus statement. Chest. 1999;115:863–866
  28. Wright J, Johns R, Watt I, Melville A, Sheldon T. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence. Br Med J. 1997;314:851–860
  29. Bolitschek J, Schmeiser-Rieder A, Schobersberger R, Rosenberger A, Kunze M, Aigner K. Impact of nasal continuous positive airway pressure treatment on quality of life in patients with obstructive sleep apnoea. Eur Respir J. 1998;11:890–894
  30. Krieger J, Meslier N, Lebrun T, Levy P, Phillip-Joet F, Sailly JC, et al. Accidents in obstructive sleep apnea patients treated with nasal continuous positive airway pressure: a prospective study. Chest. 1997;112:1561–1566
  31. Dement WC, Kushida C. Snoring and sleep quality: everyone deserves a good night's rest. Mayo Clinic Proceedings. 1999;74:1049–1050
  32. Beninati W, Harris CD, Herold D, Shepard JW. The effect of snoring and obstructive sleep apnea on the sleep quality of bed partners: the spousal arousal syndrome. Mayo Clinic Proceedings. 1999;74:955–958
  33. Wilcox I, Grunstein RR, Hedner JA, Doyle J, Collins FL, Fletcher PJ, et al. Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea. Sleep. 1993;16:539–544
  34. Hedner J, Darpo B, Ejnell H, Carlson J, Caidahl K. Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur Respir J. 1995;8:222–229
  35. Waradekar NV, Sinoway LI, Zwillich CW, LeuenÍberger UA. Influence of treatment on muscle sympathetic nerve activity in sleep apnea. Am J Respir Crit Care Med. 1996;153:1333–1338
  36. Shepard, JW, Cardiorespiratory changes in obstructive sleep apnea, Kryger MH, Roth T, Dement WC (eds). Principles and Practice of Sleep Medicine, 2ndedition. London: WB Saunders 1994; 657–666
  37. Oksenberg A, Silverberg DS, Arons E, Radwan H. The sleep supine position has a major effect on optimal nasal continuous positive airway pressure: relationship with rapid eye movements and non-rapid eye movements sleep, body mass index, respiratory disturbance, and age. Chest. 1999;116:1000–1006
  38. Series F, Marc I, Cormier Y, La Forge J. Required levels of nasal continuous positive airway pressure during treatment of obstructive sleep apnea. Eur Respir J. 1994;7:1776–1781
  39. Jokic R, Klimaszewski A, Guruswamy S, Fitzpatrick MF. Continuous positive airway pressure requirements during the first month of treatment in patients with severe obstructive sleep apnea. Chest. 1998;114:1061–1069
  40. Guilleminault C, Stoohs R, Clerk M, Cetel M, Maistros P. A cause of excessive daytime sleepiness: the upper airway resistance syndrome. Chest. 1993;104:781–787
  41. Kimoff RJ, Cheong TH, Olha AE, Charbonneau M, Levy RD, Cosio MG, et al. Mechanisms of apnea termination in obstructive sleep apnea. Role of chemoreceptor and mechanoreceptor stimuli. Am J Respir Crit Care Med. 1994;149:707–714
  42. Condos R, Norman RG, Krishnasamy I, Peduzzi N, Goldring RM, Rapoport DM. Flow limitation as a noninvasive assessment of residual upper-airway resistance during continuous positive airway pressure therapy of obstructive sleep apnea. Am J Respir Crit Care Med. 1994;150:475–480
  43. Rees K, Spence DP, Earis JE, Calverley PM. Arousal responses from apneic events during non-rapid-eye-movement sleep. Am J Respir Crit Care Med. 1995;152:1016–1021
  44. Montserrat JM, Ballester E, Olivi H, Reolid A, Lloberes P, Morello A, et al. Time-course of stepwise CPAP titration: behavior of respiratory and neurological variables. Am J Respir Crit Care Med. 1995;152:1854–1859
  45. Ayappa I, Norman RG, Hosselet JJ, Gruenke RA, Walsleben JA, Rapoport DM. Relative occurrence of flow limitation and snoring during continuous positive airway pressure titration. Chest. 1998;114:685–690
  46. Meurice JC, Paquereau J, Denjean A, Patte F, Series F. Influence of correction of flow limitation on continuous positive airway pressure efficiency in sleep apnoea/hypopnoea syndrome. Eur Respir J. 1998;11:1121–1127
  47. Sanders MH, Black J, Constantino JP, Kern N, Studnicki K, Coates J. Diagnosis of sleep-disordered breathing by half-night polysomnography. Am Rev Respir Dis. 1991;144:1256–1261
  48. Sanders MH, Kern NB, Costantino JP, Stiller RA, Studnicki K, Coates J, et al. Adequacy of prescribing positive airway pressure therapy by mask for sleep apnea on the basis of a partial night trial. Am Rev Respir Dis. 1993;147:1169–1174
  49. Yamashiro Y, Kryger MH. CPAP titration for sleep apnea using a split-night protocol. Chest. 1995;107:62–66
  50. Fleury B, Rakotonanahary D, Tehindrazanarivelo AD, Hausser-Hauw C, Lebeau B. Long-term compliance to continuous positive airway pressure therapy (nCPAP) set up during a split-night polysomnography. Sleep. 1994;17:512–515
  51. Sanders MH, Costantino JP, Strollo PJ, Studnicki K, Atwood CW. The impact of split-night Polysomnography for diagnosis and positive pressure therapy titration on treatment acceptance and adherence in sleep apnea/hypopnea. Sleep. 2000;23:17–24
  52. Lloberes P, Ballester E, Montserrat JM, Botifoll E, Ramirez A, Reolid A, et al. Comparison of manual and automatic CPAP titration in patients with sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1996;154:1755–1758
  53. Stradling JR, Barbour C, Pitson DJ, Davies RJ. Automatic nasal continuous positive airway pressure titration in the laboratory: patient outcomes. Thorax. 1997;52:72–75
  54. Juhasz J, Schillen J, Urbigkeit A, Ploch T, Penzel T, Peter JH. Unattended continuous positive irway pressure titration. Clinical relevance and cardioÍrespiratory hazards of the method. Am J Respir Crit Care Med. 1996 154;359–365
  55. Sanders MH, Rogers RM, Pennock BE. Prolonged expiratory phase in sleep apnea: a unifying hypothesis. Am Rev Respir Dis. 1985;131:401–408
  56. Schwab RJ, Gefter WB, Hoffman EA, Gupta KB, Pack AI. Dynamic upper airway imaging during awake respiration in normal subjects and patients with sleep disordered breathing. Am Rev Respir Dis. 1993;148:1385–1400
  57. Sanders MH, Kern N. Obstructive sleep apnea treated by independently adjusted inspiratory and expiratory positive airway pressures via nasal mask: physiologic and clinical implications. Chest. 1990;98:317–324
  58. Reeves-Hoche MK, Hudgel DW, Meck R, Witteman R, Ross A, Zwillich CW. Continuous versus bilevel positive airway pressure for obstructive sleep apnea. Am J Respir Crit Care Med. 1995;151:443–449
  59. Szumstein S, Atwood CW, Strollo PJ, Sanders MH. Is bilevel positive airway pressure (BPAP) an effective salvage therapy for obstructive sleep apnea (OSA) patients who fail CPAP therapy?. Am J Respir Crit Care Med. 1999;159:A250
  60. Meurice JC, Marc I, Series F. Efficacy of auto-CPAP in the treatment of obstructive sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1996;153:794–798
  61. Boudewyns A, Grillier-Lanoir V, Willemen MJ, De Cock WA, Van de Heyning PH, De Backer WA. Two months follow up of auto-CPAP treatment in patients with obstructive sleep apnea. Thorax. 1999;54:147–149
  62. Konnerman M, Sanner BM, Vylets M, Laschewski F, Groetz J, Sturm A, et al. Use of conventional and self-adjusting nasal continuous positive airway pressure for the treatment of severe obstructive sleep apnea: a comparative study. Chest. 1998;113:714–718
  63. Sforza E, Lugaresi E. Daytime sleepiness and nasal continuous positive airway pressure therapy in obstructive sleep apnea syndrome patients: effects of chronic treatment and I-night therapy withdrawal. Sleep. 1995;18:195–201
  64. Hers V, Liistro G, Dury M, Collard P, Aubert G, Rodenstein DO. Residual effect of nCPAP applied for part of the night in patients with obstructive sleep apnoea. Eur Respir J. 1997;10:973–976
  65. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet. 1994;343:572–575
  66. Sanders MH, Kern NB, Stiller RA, Strollo PJ Jr, Martin TJ, Atwood CW Jr. CPAP therapy via oroÍnasal mask for obstructive sleep apnea. Chest. 1994;106:774–779
  67. Prosise GL, Berry RB. Oral-nasal continuous positive airway pressure as a treatment for obstructive sleep apnea. Chest. 1994;106:180–186
  68. Mortimore IL, Whittle AT, Douglas NJ. Comparison of nose and face mask CPAP therapy for sleep apnoea. Thorax. 1998;53:290–292
  69. Massie CA, Hart RW, Peralez K, Richards GN. Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure. Chest. 1999;116:403–408

☆ Correspondence should be addressed to: Lt Col William Beninati, Pulmonary/Critical Care Medicine Division, 2200 Berquist Drive, Lackland AFB, TX782365300, USA.

☆☆ The views expressed in this article are those of the authors and do not reflect the official policy of the Department of Defense or the US Government.

PII: S1087-0792(00)90131-X

doi: 10.1053/smrv.2000.0131

Sleep Medicine Reviews
Volume 5, Issue 1 , Pages 7-23 , February 2001

Article Tools